CNS Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
CNS Pharmaceuticals, Inc. (CNSP) had Shares Outstanding (Cover Page) of 1.46 million shares as of 2026-08-11, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-11: Entity Common Stock, Shares Outstanding 1.46M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 1.46M shares.
- 2026-04-27: Entity Common Stock, Shares Outstanding 811.45K shares.
- 2026-03-31: Entity Common Stock, Shares Outstanding 811.45K shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 1.46M shares 10-Q · filed 2026-08-12 |
| 2026-05-13 | 1.46M shares 10-Q · filed 2026-05-14 |
| 2026-04-27 | 811.45K shares 10-K/A · filed 2026-04-30 |
| 2026-03-31 | 811.45K shares 10-K · filed 2026-03-31 |
| 2025-11-14 | 620.29K shares 10-Q · filed 2025-11-14 |
| 2025-08-14 | 574.58K shares 10-Q · filed 2025-08-14 |
| 2025-05-15 | 5.46M shares 10-Q · filed 2025-05-15 |
| 2025-03-31 | 2.94M shares 10-K/A · filed 2025-04-30 |
| 2024-11-14 | 57.49M shares 10-Q · filed 2024-11-14 |
| 2024-08-14 | 32.15M shares 10-Q · filed 2024-08-14 |
| 2024-05-15 | 11.85M shares 10-Q · filed 2024-05-15 |
| 2024-04-01 | 10.63M shares 10-K · filed 2024-04-01 |
| 2023-11-14 | 5.25M shares 10-Q · filed 2023-11-14 |
| 2023-08-11 | 4.20M shares 10-Q · filed 2023-08-14 |
| 2023-05-15 | 4.14M shares 10-Q · filed 2023-05-15 |
| 2023-03-29 | 2.23M shares 10-K · filed 2023-03-31 |
| 2022-11-10 | 40.03M shares 10-Q · filed 2022-11-10 |
| 2022-08-12 | 40.03M shares 10-Q · filed 2022-08-12 |
| 2022-05-13 | 40.03M shares 10-Q · filed 2022-05-13 |
| 2022-03-03 | 40.03M shares 10-K · filed 2022-03-03 |
| 2021-11-12 | 27.92M shares 10-Q · filed 2021-11-12 |
| 2021-08-12 | 27.46M shares 10-Q · filed 2021-08-13 |
| 2021-05-10 | 25.36M shares 10-Q · filed 2021-05-13 |
| 2021-02-12 | 25.30M shares 10-K · filed 2021-02-12 |
| 2020-11-12 | 16.65M shares 10-Q · filed 2020-11-12 |
| 2020-08-10 | 16.45M shares 10-Q · filed 2020-08-10 |
| 2020-05-15 | 16.45M shares 10-Q · filed 2020-05-15 |
| 2020-03-11 | 16.45M shares 10-K · filed 2020-03-12 |
| 2019-12-20 | 16.45M shares 10-Q · filed 2019-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |